Investment

BUSINESS

Avadel Pharma and RTW Investment License Agreement totals a whopping $75 million

On Wednesday, March 29, biopharmaceutical firm Avadel Prescribed drugs introduced its $75 million licensing settlement with RTW Investments to fund the commercialization of LUMRYZ. On the similar time, the corporate pushed again the maturity date of its $96.2 million convertible notes to 2027. Phrases of Settlement acc Yahoo Finance, the license settlement states that RTW

Scroll to Top